title: Rheumatology, rehabilitation medicine and sports and exercise medicine.
authors.affiliation: Defence Medical Rehabilitation Centre, Headley Court.
authors.forename: A
authors.initials: A
authors.lastname: Bennett
authors.forename: R
authors.initials: R
authors.lastname: Phillip
authors.forename: P
authors.initials: P
authors.lastname: Scott
authors.forename: D
authors.initials: D
authors.lastname: Minden
authors.forename: T
authors.initials: T
authors.lastname: Jones
authors.forename: A
authors.initials: A
authors.lastname: Mistlin
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy*; D000068800:Etanercept; D005081:Exercise Therapy; D005820:Genetic Testing; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D000069285:Infliximab; D008212:Lymphocyte Depletion; D008887:Military Medicine; D010024:Osteoporosis / Q000517:prevention & control; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D012046:Rehabilitation / Q000458:organization & administration*; D000069283:Rituximab; D017695:Soft Tissue Injuries / Q000628:therapy; D013178:Sports Medicine
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000069283:Rituximab; D000069285:Infliximab; D000068800:Etanercept